Therefore, it was demonstrated that targeting the SNRPB/CCNB1 axis may increase the efficacy of chemotherapy in HCC, a potential strategy for overcoming drug resistance in this malignancy. Here, CCNB1 is linked to hepatocellular carcinoma.